Manipulation of the tumor suppressor p53 for potentiating cancer therapy

被引:33
|
作者
Haupt, S
Haupt, Y [1 ]
机构
[1] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmaceut, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel
基金
以色列科学基金会;
关键词
p53; Mdm2; therapy; DNA damage; small molecules;
D O I
10.1016/j.semcancer.2004.04.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The tumor suppressor p53 is a linchpin in the regulation of appropriate cellular responses to various stress conditions. Inactivation of the functions of this critical participant can have diabolical consequences, in particular the development of malignant diseases. Elicitation of appropriate p53 functions is an attractive strategy for combating cancer. Triggering p53 responses, reconstituting p53 activities through gene therapy, coercing mutant p53 to perform normal functions, manipulating p53 regulators, and activating p53 effectors are all approaches that are currently being developed. Here, we will overview 'p53-based' strategies for fighting cancer, both those under clinical trial and recent innovative concepts. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:244 / 252
页数:9
相关论文
共 50 条
  • [21] APOPTOSIS, CANCER AND THE P53 TUMOR-SUPPRESSOR GENE
    LEE, JM
    BERNSTEIN, A
    [J]. CANCER AND METASTASIS REVIEWS, 1995, 14 (02) : 149 - 161
  • [22] Alterations in p53 tumor suppressor gene in lung cancer
    Zalcman, G
    Soussi, T
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2000, 17 (01) : 329 - 349
  • [23] p53: The Attractive Tumor Suppressor in the Cancer Research Field
    Ozaki, Toshinori
    Nakagawara, Akira
    [J]. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,
  • [24] Functional characterization of p53β and p53γ, two isoforms of the tumor suppressor p53
    Graupner, Vilma
    Schulze-Osthoff, Klaus
    Essmann, Frank
    Jaenicke, Reiner U.
    [J]. CELL CYCLE, 2009, 8 (08) : 1238 - 1248
  • [25] Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy
    Bressy, Christian
    Hastie, Eric
    Grdzelishvili, Valery Z.
    [J]. MOLECULAR THERAPY-ONCOLYTICS, 2017, 5 : 20 - 40
  • [26] p53 tumor suppressor gene: At the crossroads of molecular carcinogenesis, molecular epidemiology and cancer therapy
    Wang, XW
    Jia, L
    Bennett, WP
    Elmore, LW
    Harris, CC
    [J]. BRITISH JOURNAL OF CANCER, 1996, 74 : SP17 - SP17
  • [27] In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer
    Spitz, FR
    Nguyen, D
    Skibber, JM
    Cusack, J
    Roth, JA
    Cristiano, RJ
    [J]. ANTICANCER RESEARCH, 1996, 16 (6B) : 3415 - 3422
  • [28] Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide
    Bernal, Federico
    Tyler, Andrew F.
    Korsmeyer, Stanley J.
    Walensky, Loren D.
    Verdine, Gregory L.
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (09) : 2456 - +
  • [29] Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide
    Bernal, Federico
    Tyler, Andrew F.
    Korsmeyer, Stanley J.
    Walensky, Loren D.
    Verdine, Gregory L.
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (16) : 5298 - 5298
  • [30] p53 isoforms - A conspiracy to kidnap p53 tumor suppressor activity?
    V. Marcel
    P. Hainaut
    [J]. Cellular and Molecular Life Sciences, 2009, 66